SMITH HUNTER C (Chief Financial Officer) sold 5.0% of their position (6.63K shares) of RHYTHM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $702.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 2/6/2026ACC: 0001104659-26-011651
Officer· Chief Financial Officer
Since Mar 2026
-6.63K
Net shares
Net seller
$702.7K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
6.63K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−1.50K
Price / share
$104.74
Trade value
$157.12K
% of position
1.1%
2/4/2026
132.16K→130.66K
Common Stock
Direct
Shares
−1K
Price / share
$106.60
Trade value
$106.60K
% of position
0.8%
2/4/2026
130.66K→129.66K
Common Stock
Direct
Shares
−747.00
Price / share
$107.67
Trade value
$80.43K
% of position
0.6%
2/4/2026
129.66K→128.92K
Common Stock
Direct
Shares
−3.38K
Price / share
$106.06
Trade value
$358.60K
% of position
2.6%
2/5/2026
128.92K→125.54K
Total
Net shares
−6.63K
Net value
-$702.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2026 | S · Sale | −1.50K | $104.74 | $157.12K | 1.1% | 132.16K | 130.66K |
| Common Stock Direct | 2/4/2026 | S · Sale | −1K | $106.60 | $106.60K | 0.8% | 130.66K | 129.66K |
| Common Stock Direct | 2/4/2026 | S · Sale | −747.00 | $107.67 | $80.43K | 0.6% | 129.66K | 128.92K |
| Common Stock Direct | 2/5/2026 | S · Sale | −3.38K | $106.06 | $358.60K | 2.6% | 128.92K | 125.54K |
| Total | −6.63K | -$702.74K | ||||||
Derivative Transactions0
No derivative transactions reported